Tetrapropylammonium → 1-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one

HRID 1409739

反応式

HRID 1409739 の反応式
[CH3:1][CH:2]([C:4]1[N:8]=[C:7]([N:9]2[CH2:14][CH2:13][CH:12]([OH:15])[CH2:11][CH2:10]2)[O:6][N:5]=1)[CH3:3].C[N+]1([O-])CCOCC1.C([N+](CCC)(CCC)CCC)CC>ClCCl>[CH3:3][CH:2]([C:4]1[N:8]=[C:7]([N:9]2[CH2:10][CH2:11][C:12](=[O:15])[CH2:13][CH2:14]2)[O:6][N:5]=1)[CH3:1]

参加物

5

反応物 3

HCID 9559TetrapropylammoniumHCID 82029Methyl morpholine oxideHCID 218977441-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-OL

生成物 1

HCID 669153481-(3-Isopropyl-1,2,4-oxadiazol-5-YL)piperidin-4-one

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

1-[3-(Propan-2-yl)-1,2,4-oxadiazol-5-yl]piperidin-4-ol (0.5 g) is dissolved in dichloromethane (75 mL) and 4 A molecular sieves (4 g) are added followed by N-methylmorpholine-N-oxide (1.52 g) and tetrapropylammonium perrhutenate (0.018 g) and the mixture is stirred at room temperature for 1 h. The reaction is then filtered through celite and the mother liquor washed with water (2×50 mL). The water layers are then combined and back extracted with dichloroemthane (100 mL). The dichloromethane layers are combined, dried over Na2SO4, filtered and concentrated to give the title compound. LC (method 20): tR=1.67 min; Mass spectrum (APCI): m/z=210 [M+H]+.

後処理

  1. addition4 A molecular sieves (4 g) are added
  2. filtrationThe reaction is then filtered through celite
  3. washthe mother liquor washed with water (2×50 mL)
  4. extractionback extracted with dichloroemthane (100 mL)
  5. dry with materialdried over Na2SO4
  6. filtrationfiltered
  7. concentrationconcentrated

出典と根拠

ORDレコード
ord-38fbc51127124e7badac6fcceb6e2ec6
出典データセット
uspto-grants-2014_12
特許番号
US08921398B2

関連ノート

読み込み中…